What is the official website of Sandoz Srbija ?

The official website of Sandoz Srbija is https://www.sandoz.rs/.

What is Sandoz Srbija's cybersecurity risk score?

Sandoz Srbija has an AI-generated cybersecurity risk score of 758 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sandoz Srbija experienced?

According to Rankiteo, Sandoz Srbija currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sandoz Srbija been affected by any supply chain cyber incidents ?

According to Rankiteo, Sandoz Srbija has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sandoz Srbija have SOC 2 Type 1 certification ?

According to Rankiteo, Sandoz Srbija is not certified under SOC 2 Type 1.

Does Sandoz Srbija have SOC 2 Type 2 certification ?

According to Rankiteo, Sandoz Srbija does not hold a SOC 2 Type 2 certification.

Does Sandoz Srbija comply with GDPR ?

According to Rankiteo, Sandoz Srbija is not listed as GDPR compliant.

Does Sandoz Srbija have PCI DSS certification ?

According to Rankiteo, Sandoz Srbija does not currently maintain PCI DSS compliance.

Does Sandoz Srbija comply with HIPAA ?

According to Rankiteo, Sandoz Srbija is not compliant with HIPAA regulations.

Does Sandoz Srbija have ISO 27001 certification ?

According to Rankiteo,Sandoz Srbija is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sandoz Srbija operate in ?

Sandoz Srbija operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sandoz Srbija have ?

Sandoz Srbija employs approximately 35 people worldwide.

Does Sandoz Srbija own any subsidiaries ?

Sandoz Srbija presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sandoz Srbija have ?

Sandoz Srbija's official LinkedIn profile has approximately 1,110,405 followers.

What is the NAICS classification code for Sandoz Srbija ?

Sandoz Srbija is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sandoz Srbija have a Crunchbase profile ?

No, Sandoz Srbija does not have a profile on Crunchbase.

Does Sandoz Srbija have a LinkedIn profile ?

Yes, Sandoz Srbija maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sandozsrbija.

How many cybersecurity incidents has Sandoz Srbija experienced ?

As of June 9, 2026, Rankiteo reports that Sandoz Srbija has not experienced any cybersecurity incidents.

How many peer or competitor companies does Sandoz Srbija have ?

Sandoz Srbija has an estimated 5,682 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Sandoz Srbija

Boost Score +25 with badge (5 left)

758

/1000

Fair

783

/1000

Fair

Sandoz Srbija Vendor Cyber Rating & Cyber Score

sandoz.rs

Add Your Compliance Badge

Sandoz je globalni lider u generičkim i biosimilarnim lekovima. Naša svrha je pionirski pristup lekovima za pacijente širom sveta. Mi smo na misiji da pokrenemo inovacije u zdravstvenoj industriji oslobađajući resurse na održiv i odgovoran način, dok nastavljamo da se bavimo globalnim zdravstvenim izazovima kao što je otpornost na antimikrobne lekove. Prisutni smo u više od 100 zemalja i naši lekovi služe oko 500 miliona ljudi svake godine. Imamo dva glavna globalna poslovanja: generičke lekove – podeljene između standardnih generičkih i složenih generičkih lekova – i biosimilare.

Sandoz Srbija A.I CyberSecurity Scoring

Scoring History

Sandoz Srbija

Sandoz Srbija CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Sandoz Srbija Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Sandoz Srbija

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Srbija in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sandoz Srbija in 2026.

Incident Types Sandoz Srbija vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Srbija in 2026.

Incident History - Sandoz Srbija (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sandoz Srbija Subsidiaries

Sandoz Srbija

Pharmaceutical Manufacturing

Website: https://www.sandoz.rs/

Company Size: 11-50 employees

SandozPharmaceutical Manufacturing

Sandoz EgyptPharmaceutical Manufacturing

Sandoz do BrasilFabricação de produtos farmoquímicos e farmacêuticos

Lek PharmaceuticalsPharmaceutical Manufacturing

Sandoz ItaliaPharmaceutical Manufacturing

Sandoz ÖsterreichPharmaceutical Manufacturing

Sandoz India Pvt LtdPharmaceutical Manufacturing

Sandoz UK & IrelandPharmaceutical Manufacturing

Sandoz IberiaPharmaceutical Manufacturing

Sandoz RomaniaPharmaceutical Manufacturing

Sandoz BelgiumPharmaceutical Manufacturing

Sandoz Czech RepublicPharmaceutical Manufacturing

Sandoz HrvatskaPharmaceutical Manufacturing

Sandoz SverigePharmaceutical Manufacturing

Sandoz HungáriaPharmaceutical Manufacturing

Sandoz in DeutschlandPharmaceutical Manufacturing

Sandoz MéxicoPharmaceutical Manufacturing

Sandoz DanmarkPharmaceutical Manufacturing

Sandoz Australia & New ZealandPharmaceutical Manufacturing

Sandoz FrancePharmaceutical Manufacturing

Sandoz PolskaPharmaceutical Manufacturing

Sandoz NederlandPharmaceutical Manufacturing

Life at SandozArzneimittelherstellung

Sandoz CanadaPharmaceutical Manufacturing

Loading…

Sandoz Srbija Similar Companies

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Novartis

cb novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Loading…

NEWS

Sandoz Srbija CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-44541

SUMMARY

Fides is an open-source privacy engineering platform. From version 2.33.0 to before version 2.84.5, there is a DOM-based XSS vulnerability in fides.js via the fides_description override. This issue has been patched in version 2.84.5.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: )

cvss4

Base Score: 7.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-49141

SUMMARY

WACRM prior to commit 73041bf contain an authorization bypass vulnerability in the automation engine that allows authenticated attackers to access and modify contacts belonging to other tenants by supplying an arbitrary caller-controlled contact_id in the POST request body without tenant ownership verification. Attackers can exploit the service-role client that bypasses row-level security to modify victim contact fields including name, email, and company across tenant boundaries using only a known contact UUID.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:H/A:N

cvss4

Base Score: 5.1

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.7

Exploitability

1.8

REFERENCES

CVE-2026-47345

SUMMARY

Namespace attributes are not encoded correctly during HTML serialization. This allows bypassing the cross-site scripting prevention mechanism of typo3/html-sanitizer before version 2.3.2.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: )

cvss4

Base Score: 5.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-47344

SUMMARY

When ALLOW_INSECURE_RAW_TEXT is enabled, whitespace-variant closing tags (e.g., </style\t>) are not recognized by the sanitizer but accepted by browsers as valid end tags, allowing subsequent content to escape sanitization. This allows bypassing the cross-site scripting prevention mechanism of typo3/html-sanitizer before version 2.3.2.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: )

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-46484

SUMMARY

Headplane is a feature-complete Web UI for Headscale. Prior to versions 0.6.3 and 0.7.0-beta.3, Headplane was vulnerable to a path traversal / authorization bypass in the Headscale API client used by node and user rename operations. This issue has been patched in versions 0.6.3 and 0.7.0-beta.3.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H

Impact Score

5.2

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…